NCI

Forecast & Rating13 analysts currently cover NCI, with about 38.5% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$50.57, about 4.6% upside from the current price of HK$48.36. Price targets range from HK$37.36 to HK$64.42 — a wide spread, showing clear disagreement over just how much NCI can rise. Historically, about 44.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on NCI's outlook. Data as of Jul 31, 2026; for reference only and not investment advice.